EATG » Cure

Cure

Early antiretroviral therapy dramatically reduces HIV DNA set point

Findings from new MHRP study hold clues to reducing HIV reservoir size A team of researchers, led by Drs. Merlin Robb and Jintanat Ananworanich of the U.S. Military HIV Research…

Post-ART and no-ART controllers similar in primary infection trial/cure trials

People with primary HIV infection who controlled viral replication spontaneously in the randomized SPARTAC trial were similar in many respects to people who controlled viremia after short-course antiretroviral therapy (ART)…

Searching for the next ‘Berlin patient’: doctors document bone-marrow recipients with HIV

The ‘Berlin patient’, Timothy Ray Brown, has now survived seven years off antiretroviral therapy with no sign of HIV reappearing in his body, and as time passes his position as…

STEPS – Community Cure Workshop at the Glasgow HIV Therapy Congress

If you are planning to attend the HIV Therapy congress in Glasgow (23-26 October 2016, http://hivglasgow.org/), you are invited to apply to the cure community meeting organised by EATG: STEPS -…

A cure for HIV: what science knows, and what it doesn’t

Antiretroviral therapy has revolutionised the lives of people living with HIV. In many countries, the life expectancy for someone living with the virus is now almost the same as someone…

Immune-enhancing treatment may destabilize HIV reservoirs

NIH-funded study in monkeys suggests promise of targeting PD-1 Although antiretroviral therapy (ART) can reduce the amount of HIV in the blood to an undetectable level in most chronically infected…

HIV will only be cured with combinations too, conference delegates hear

Curing people of HIV infection will have to involve combinations of drugs and approaches, just as HIV treatment does, delegates heard at the Towards a Cure workshop held in advance…

Researchers seek to repeat the Berlin Patient’s HIV cure

Investigators have created a consortium in an effort to yield HIV cures through stem cell transplants similar to the cure achieved in the Berlin Patient, the man whose HIV and…

Latest HIV cure data expose resilience of infection

DURBAN, South Africa, July 19, 2016 — Disappointing results from a trial of a latency-reversing strategy for HIV underscore the challenges researchers are facing in their search for a functional cure for the…

Young women treated in very early HIV infection stay HIV negative and preserve immune function

A group of young South African women who were diagnosed in very early infection and immediately given antiretroviral therapy (ART) preserved their CD4 counts and the function of cells that…